The public issue is entirely an offer-for-sale (OFS) of up to 21.7 million shares by the promoters and other shareholders to the tune of around ₹1,800 crore, said bankers. The company operates under the “Blue Jet” brand offering niche products targeted at innovator pharmaceutical companies and multinational generic pharmaceutical companies.
Ashok Leyland 1:1 bonus issue record date tomorrow. Do you own?
Investors eyeing Ashok Leyland’s 1:1 bonus issue should note July 15 as the last day to buy shares for eligibility. The company has set July